Furazabol

from Wikipedia, the free encyclopedia
Structural formula
Structure of Furazabol
General
Non-proprietary name Furazabol
other names

17 α -methyl-5 α -androsta-2,3-furazan-17 β -ol

Molecular formula C 20 H 30 N 2 O 2
External identifiers / databases
CAS number 1239-29-8
EC number 214-983-0
ECHA InfoCard 100.013.621
PubChem 14708
ChemSpider 14032
DrugBank DB01514
Wikidata Q411537
Drug information
ATC code

A14 AA

Drug class

Anabolic steroids

properties
Molar mass 330.46 g · mol -1
Physical state

firmly

Melting point

152-153 ° C

safety instructions
Please note the exemption from the labeling requirement for drugs, medical devices, cosmetics, food and animal feed
GHS hazard labeling
no classification available
Toxicological data

> 4000 mg kg −1 ( LD 50 ,  rat ,  oral )

As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions .

Furazabol is a derivative of the anabolic steroid Stanozolol . It differs from stanozolol in that it has a ring-shaped furazan group (oxadiazole) instead of the pyrazole group. Furazabol was marketed in Japan under the trade name Miotolan , which was formerly registered by Daiichi Seiyaku KK , but is now out of distribution.

The duration of taking Furazabol should be limited to 6 to 8 weeks because of its liver toxicity . The steroid is used by athletes in athletics and bodybuilding to improve performance. The ingestion of Furazabol is detectable up to 14 days after ingestion. According to the doping agent quantity regulation of July 8, 2016, 100 mg Furazabol are to be regarded as a "not small quantity".

literature

  • Kim, T. et al. (1996): Excretion study of furazabol, an anabolic steroid, in human urine. In: J. Chromatogr. B. Biomed. Appl. 687 (1): 79-83. PMID 9001955 .

Individual evidence

  1. ^ The Merck Index , 9th Edition, Merck & Co., 1976, pp. 553-554 ISBN 0-911910-26-3 .
  2. ↑ This substance has either not yet been classified with regard to its hazardousness or a reliable and citable source has not yet been found.
  3. ↑ Entry on Furazabol in the ChemIDplus database of the United States National Library of Medicine (NLM) .
  4. ↑ ABDA database (as of December 4, 2009).
  5. ↑ a b entry on Furazabol. In: Römpp Online . Georg Thieme Verlag, accessed on July 2, 2019.

Web links